Document Mentions (3 shared documents)

EFTA02686105

2 mentions1 same-page

Page ?Same page

tuart Evans Bob Every Dean Chief Executive Officer President and Chief Executive Officer Chief Executive Officer Chief Executive Officer Head, Pharma Division Chief Executive Officer, Asset Management Chairman, President and Chief Executive Officer Editor-in-Chief, Magazines Vice-President, Corporate

oland Berger Honorary Chairman Roland Berger Strategy Germany Consultants Holding GmbH Douglas G. Bergeron Chairman and Chief Executive Officer VeriFone Systems Inc. USA Nicolas Berggruen President and Chairman Nicolas Berggruen Institute USA Stanley M. Bergman Chairman of the Board and Chief Henry Schein I

EFTA02686169

2 mentions1 same-page

Page ?Same page

Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, P

land Berger Honorary Chairman Roland Berger Strategy Germany Consultants Holding GmbH Douglas G. Bergeron Chairman and Chief Executive Officer VeriFone Systems Inc. USA Nicolas Berggruen President and Chairman Nicolas Berggruen Institute USA Stanley M. Bergman Chairman of the Board and Chief Henry Schein

EFTA02686246

2 mentions1 same-page

Page ?Same page

Mutual Connections (2,063)

Entities connected to both Pharma Division and VeriFone Systems Inc.

The Coca-Cola Company